Bio Rad Laboratories Inc expected to post earnings of $2.78 a share - Earnings Preview

Bio-Rad Laboratories

24/10/2023 21:06

* Bio Rad Laboratories Inc  BIO.N   BIO  is expected to show
a
rise in quarterly revenue when it reports  results on October
26. 
    * The Hercules California-based  company is expected to
report  a
1.3% increase in revenue to $689.566 million from $680.8 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bio Rad
Laboratories Inc
is for earnings of $2.78 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bio Rad
Laboratories Inc is $525​, above​ its last closing price
of $301.90. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  2.68        2.68       3.00      Beat    12
 Mar. 31 2023  3.59        3.54       3.34      Missed  -5.7
 Dec. 31 2022  3.43        3.45       3.31      Missed  -4​
 Sep. 30 2022  2.83        2.78       2.60      Missed  -6.5
 ​​Jun.        2.90        2.80       3.38      Beat    20.8
 30 2022                                                
 Mar. 31 2022  3.45        3.40       4.94      Beat    45.2​
 Dec. 31 2021  2.86        2.85       3.21      Beat    12.6
 Sep. 30 2021  2.47        2.44       3.71      Beat    52.2
 This summary was machine generated October 24 at 20:06 GMT.  All
figures in US dollars  unless otherwise stated